Back to results
US 2026/0158096 A1Published application
Methods and Formulations for Immuno-Rejuvenation to Prevent or Mitigate Inflammaging Through the Epigenetic Impact of a Polyphenol-Rich Agent Derived from Uniquely Applied Tartary Buckwheat
AssigneeBig Bold Health
InventorsJeffrey S. Bland, Austin Perlmutter
Life of this patent
Estimating the term…
Abstract
Development of producing certain methods of and nutrition management of Tartary buckwheat (Fagopyrum Tataricum) to promote immuno-rejuvenation by influencing key pathways involved in aging, inflammation and immune system function.
Claims8
The process of inhibiting biologic aging in human or domesticated animal subject by certain administration steps of Tartary buckwheat utilizing enhanced amounts of polyphenol-rich agents administered in dosages effective for particular categories of subjects to elevate immune function through epigenetic alteration by steps of:
- (a) creating an enhanced form of Tartary buckwheat by cold environment seed or root planting harvested at post germination sprouting stage and adding beneficial microorganisms at seeding and/or growth stages pre-sprouting guided by methylation patterns;
- (b) micronization processing of the harvested material to powder, leaf capsules or liquid forms for ingestion in diet and/or blood system inoculation, the beneficial microorganisms being selected from the group consisting of symbiotic bacterial, mycorrhizal fungi, singly or in combinations, thereof;
- (c) further adding at sprout stage or subsequently in dosing in diet and/or inoculation additives selected from the group of omega-3 fatty acids, probiotics, prebiotics, vitamins, minerals, fermented products or other nutraceuticals, singly and/or any combination;
- (d) adjusting diet or inoculation of a subject in relation to one or more singly or any combination markers from the group consisting of a subject's genomic instability, telomere alteration, epigenetic alteration, loss of proteostasis, deregulated nutrient sensing, mitochondrial, dysfunction, cellular senescence, stem cell, exhaustion, altered intercellular communication;
- (e) managing over a selected term of a group consisting of a program of such diet and/or inoculation effects and if indicated revising the program to measure improvement of immune function, biological aging through increased epigenetic alterations through a pattern of CpG alterations and/or inhibition of pro-inflammatory cytokines including IL-6, TNF-alpha or beneficial alterations in the immune system including positive changes to innate or adaptive immune cell makeup.
2 more elements
Dependencies are inferred from the claim text.